Results 221 to 230 of about 35,609 (237)

The Less-Efficient-Market Hypothesis

The Journal of Portfolio Management
openaire   +2 more sources

Stem cell therapy market

Nature Reviews Drug Discovery, 2013
exaly  

The gastroesophageal cancer drug market

Nature Reviews Drug Discovery, 2018
exaly  

On the Efficient Markets Hypothesis

2006
openaire   +1 more source

The cystic fibrosis drug market

Nature Reviews Drug Discovery, 2014
exaly  

The dyslipidaemia market

Nature Reviews Drug Discovery, 2014
exaly  

On the Efficient Markets Hypothesis

2001
openaire   +1 more source

The HIV therapy market

Nature Reviews Drug Discovery, 2016
exaly  

The neuropathic pain market

Nature Reviews Drug Discovery, 2012
exaly  

The ovarian cancer drug market

Nature Reviews Drug Discovery, 2017
exaly